Search Results
Search for other papers by Kun Chen in
Google Scholar
PubMed
Search for other papers by Ji-Dan Zhou in
Google Scholar
PubMed
Search for other papers by Feng Zhang in
Google Scholar
PubMed
Search for other papers by Fang Zhang in
Google Scholar
PubMed
Search for other papers by Rui-Rui Zhang in
Google Scholar
PubMed
Search for other papers by Meng-Si Zhan in
Google Scholar
PubMed
Search for other papers by Xiao-Yin Tang in
Google Scholar
PubMed
Search for other papers by Bing Deng in
Google Scholar
PubMed
Search for other papers by Ming-Gang Lei in
Google Scholar
PubMed
Search for other papers by Yuan-Zhu Xiong in
Google Scholar
PubMed
Tsujimoto G 2005 Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120 . Nature Medicine 11 90 – 94 . ( doi:10.1038/nm1168 ). Ichimura A Hirasawa A Poulain-Godefroy O Bonnefond A Hara T Yengo L Kimura
Search for other papers by Ping Li in
Google Scholar
PubMed
Search for other papers by Yan Hao in
Google Scholar
PubMed
Search for other papers by Feng-Hui Pan in
Google Scholar
PubMed
Search for other papers by Min Zhang in
Google Scholar
PubMed
Search for other papers by Jian-Qiang Ma in
Google Scholar
PubMed
Search for other papers by Da-Long Zhu in
Google Scholar
PubMed
investigate the effect of SGK1 inhibitors on the secretion of incretin. Excessive glucocorticoids result in whole-body insulin resistance, obesity, and hyperglycemia ( Geer et al . 2014 ). Metabolic syndrome shares many clinical features with excess
Search for other papers by Daiana Araujo Santana-Oliveira in
Google Scholar
PubMed
Search for other papers by Aline Fernandes-da-Silva in
Google Scholar
PubMed
Search for other papers by Carolline Santos Miranda in
Google Scholar
PubMed
Search for other papers by Fabiane Ferreira Martins in
Google Scholar
PubMed
Search for other papers by Carlos Alberto Mandarim-de-Lacerda in
Google Scholar
PubMed
Search for other papers by Vanessa Souza-Mello in
Google Scholar
PubMed
incretin hormone action . Cell Metabolism 17 819 – 837 . ( https://doi.org/10.1016/j.cmet.2013.04.008 ) 23684623 Chen FJ Yin Y Chua BT Li P 2020 CIDE family proteins control lipid homeostasis and the development of metabolic diseases . Traffic
Diabetes Research Center, Department of Clinical Chemistry and Radioimmunology, Department of Medical Biochemistry, Department of Biomedical Sciences, Brussels Free University (VUB), Laarbeeklaan 103, B1090 Brussel, Belgium
Search for other papers by G A Martens in
Google Scholar
PubMed
Search for other papers by E Motté in
Google Scholar
PubMed
Search for other papers by G Kramer in
Google Scholar
PubMed
Search for other papers by G Stangé in
Google Scholar
PubMed
Search for other papers by L W Gaarn in
Google Scholar
PubMed
Search for other papers by K Hellemans in
Google Scholar
PubMed
Search for other papers by J H Nielsen in
Google Scholar
PubMed
Search for other papers by J M Aerts in
Google Scholar
PubMed
Search for other papers by Z Ling in
Google Scholar
PubMed
Search for other papers by D Pipeleers in
Google Scholar
PubMed
vesicle exocytosis, and incretin signaling. Our data argue against this: in fact, when specifically analyzed by oligonucleotide array for their mRNA expression of a large panel of conserved β cell marker genes ( Martens et al . 2011 ), neonatal β cells
Search for other papers by Haihua Yang in
Google Scholar
PubMed
Search for other papers by Linghai Yang in
Google Scholar
PubMed
homeostasis by cAMP/PKA pathway in pancreatic β cell, hepatocyte, and adipocyte. (A) Regulation of insulin production by cAMP/PKA signaling in pancreatic β cell. Upon stimulation by incretins such as glucagon-like peptide 1 (GLP1), PKA is activated to promote
Search for other papers by Brenda Vidrio-Huerta in
Google Scholar
PubMed
Search for other papers by Thomas Plötz in
Google Scholar
PubMed
Search for other papers by Stephan Lortz in
Google Scholar
PubMed
hypoglycaemia to maturity-onset diabetes of the young, and incretin response . Diabetic Medicine 31 e11 – e15 . ( https://doi.org/10.1111/dme.12369 ) Bestetti S Galli M Sorrentino I Pinton P Rimessi A Sitia R & Medrano-Fernandez I 2020 Human
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Zhaoqian Xu in
Google Scholar
PubMed
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Yiru Wang in
Google Scholar
PubMed
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Qianqian Liu in
Google Scholar
PubMed
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Shushu Wang in
Google Scholar
PubMed
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Chunxiang Sheng in
Google Scholar
PubMed
Academy of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China
Search for other papers by Junmin Chen in
Google Scholar
PubMed
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Jialin Tan in
Google Scholar
PubMed
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Xiao Wang in
Google Scholar
PubMed
Search for other papers by Li Shao in
Google Scholar
PubMed
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Libin Zhou in
Google Scholar
PubMed
Menshikov M Vorotnikov AV Parfyonova YV , 2019 Low AS160 and high SGK basal phosphorylation associates with impaired incretin profile and type 2 diabetes in adipose tissue of obese patients . Diabetes Research and Clinical Practice 158 107928
Search for other papers by Sheng Y Ang in
Google Scholar
PubMed
Search for other papers by Bronwyn A Evans in
Google Scholar
PubMed
Search for other papers by Daniel P Poole in
Google Scholar
PubMed
Search for other papers by Romke Bron in
Google Scholar
PubMed
Search for other papers by Jesse J DiCello in
Google Scholar
PubMed
Department of Biochemistry and Molecular Biology, University of Melbourne, Melbourne, Victoria, Australia
Search for other papers by Ross A D Bathgate in
Google Scholar
PubMed
Department of Biochemistry and Molecular Biology, University of Melbourne, Melbourne, Victoria, Australia
Search for other papers by Martina Kocan in
Google Scholar
PubMed
Department of Pharmacology, Monash University, Clayton, Victoria, Australia
Search for other papers by Dana S Hutchinson in
Google Scholar
PubMed
Search for other papers by Roger J Summers in
Google Scholar
PubMed
transcriptome . Genome Research 23 1554 – 1562 . ( https://doi.org/10.1101/gr.150706.112 ) 23716500 10.1101/gr.150706.112 Ørskov C Wettergren A Holst JJ 1996 Secretion of the incretin hormones glucagon-like peptide-1 and gastric inhibitory
Division of Advanced Diagnostics, Toronto General Hospital Research Institute, University Health Network, Toronto, Canada
Search for other papers by Jianqiu Gu in
Google Scholar
PubMed
Search for other papers by Weijuan Shao in
Google Scholar
PubMed
Department of Cardiology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, People’s Republic of China
Search for other papers by Dinghui Liu in
Google Scholar
PubMed
Department of Physiology, Temerty Faculty of Medicine, University of Toronto, Toronto, Canada
Search for other papers by Jia Nuo Feng in
Google Scholar
PubMed
Department of Nutrition, School of Public Health, Sun Yat-sen University, Guangzhou, People’s Republic of China
Search for other papers by Juan Pang in
Google Scholar
PubMed
Department of Physiology, Temerty Faculty of Medicine, University of Toronto, Toronto, Canada
Banting and Best Diabetes Centre, Temerty Faculty of Medicine, University of Toronto, Toronto, Canada
Search for other papers by Tianru Jin in
Google Scholar
PubMed
tolerance. Following the recognition of GLP-1 as an incretin ( Mojsov et al. 1987 ), GLP-1R has been identified and its expression in pancreatic islets and elsewhere has been investigated by various means ( Campos et al. 1994 , Bullock et al. 1996
Search for other papers by He-jun Zhao in
Google Scholar
PubMed
Search for other papers by Xia Jiang in
Google Scholar
PubMed
Search for other papers by Li-juan Hu in
Google Scholar
PubMed
Search for other papers by Lei Yang in
Google Scholar
PubMed
Search for other papers by Lian-dong Deng in
Google Scholar
PubMed
Search for other papers by Ya-ping Wang in
Google Scholar
PubMed
Search for other papers by Zhi-peng Ren in
Google Scholar
PubMed
drugs in patients complicated with pancreatic cancer and diabetes mellitus has important clinical significance. Glucagon-like peptide 1 (GLP-1) is known as an incretin hormone secreted from intestinal endocrine cells, and it augments insulin production